Australia has made a groundbreaking decision by becoming the first country to legalise the clinical prescribing of MDMA (ecstasy) and psilocybin (magic mushrooms) for the treatment of specific mental health disorders, including PTSD and treatment-resistant depression. Setting Australia apart as the pioneer in adopting psychoactive-based treatments for mental health, as of 1 July, authorised psychiatrists
Read More
Biopharmaceutical company Dimerix (ASX: DXB) has won the favour of the Paediatric Committee (PDCO) of the European Medicines Agency (EMA), as the committee has formally accepted Dimerix’s Paediatric Investigation Plan for the development of DMX-200, a potential treatment for kidney disease. The PDCO’s approval comes after a meeting on June 23, 2023, and paves the
Read More
There is little joy in the Happy Valley (ASX: HVM) offices today, as the infant formula company enters voluntary administration. “It is disappointing to announce the appointment of administrators today,” the Chairman of the Company, Kevin Bush, stated grimly in an announcement. Due to dwindling global infant milk supply, HVM was able to thrive during
Read More
We’re fast approaching tax time, which means Aussies need to brace themselves for the great battle of having to wait to speak to the Australian Taxation Office (ATO) should they have any enquiries while lodging their tax return. This is not an exaggeration, though. ATO call centres are said to be unable to meet demand
Read More
Australian counterdrone solutions company DroneShield (ASX: DRO) has been awarded a two-year research and development contract worth $9.9 million by the Five Eyes Department of Defence (DoD). This substantial contract highlights DroneShield’s growing prominence in the defence industry and signifies the confidence placed in the Company’s capabilities by the Five Eyes intelligence alliance, comprising the
Read More
What’s in a brand name, when household income has been squeezed to its very last drop? Rising costs have compelled people to opt for generic meds instead of branded ones to save a few bucks wherever possible. And now, meds for chronic anal fissure pain are set to get a generic version, thanks to pharma
Read More
High energy costs have spared no one, neither customers nor companies. That’s why it has become integral to keep tabs on what’s emptying the corporate wallet and reign in the costs. To help with that, smart energy SaaS company Simble (ASX: SIS) is offering data analysis and carbon emission tracking platforms to help companies review
Read More
Diagnostic tech company Lumos Diagnostics (ASX: LDX) has received the green card from the US Food and Drug Administration (FDA) to market its FebriDx rapid, point-of-care test in the United States. This regulatory clearance permits the marketing of FebriDx in the US as an aid for healthcare professionals in diagnosing bacterial acute respiratory infections and
Read More
As companies take on more ambitious endeavors, be it diving under the sea or exploring natural gas hidden deep beneath the surface, communication becomes more and more integral. But remote connectivity is no cakewalk, which is where remote tech provider companies like Harvest Technology Group (ASX: HTG) come into play. The Perth-based Company, which provides
Read More
Eye health has been in and out of sight and mind for some time now, urging organisations to demand greater investment and attention towards Aussies’ unmet needs. In 2018, 93% of Aussies aged over 65 reported vision disorders, and the pandemic did little to help by not being a sight for sore eyes. If that
Read More
